NVO
USDNovo Nordisk A/S Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$46.220
High
$46.360
Low
$45.570
Volume
37.86M
Company Fundamentals
Market Cap
210.1B
Industry
Drug Manufacturers - General
Country
Denmark
Trading Stats
Avg Volume
15.16M
Exchange
NYQ
Currency
USD
52-Week Range
Related News
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.
November trading, Berkshire's cash hoard, Big Tech's ad revenue and more in Morning Squawk
Here are five key things investors need to know to start the trading day.
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound
Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.